Genetic Variants in the Fat and Obesity Associated (FTO) Gene and Risk of Alzheimer's Disease

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Reitz, Christiane ^a,b   Tosto, Giuseppe ^a   Mayeux, Richard ^a,b   Luchsinger, Jose A ^a  

^a Columbia University ^*  (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BRAIN CORTEX; CAUCASIAN; CONTROLLED STUDY; ENDOPHENOTYPE; EXON; FEMALE; FTO GENE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HAPLOTYPE; HISPANIC; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NEUROPATHOLOGY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; ENDOPHENOTYPES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS;

EID: 84871206725     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050354     Document Type: Article

References (54)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM, (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3: 186-191.
2. Green RC, Schneider LS, Amato DA, Beelen AP, Wilcock G, et al. (2009) Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA 302: 2557-2564.
3. Lu FP, Lin KP, Kuo HK, (2009) Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One 4: e4144.
4. Profenno LA, Porsteinsson AP, Faraone SV, (2010) Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 67: 505-512.
5. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I, (2003) An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 163: 1524-1528.
6. Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O'Meara ES, et al. (2009) Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 66: 336-342.
7. Nourhashemi F, Deschamps V, Larrieu S, Letenneur L, Dartigues JF, et al. (2003) Body mass index and incidence of dementia: the PAQUID study. Neurology 60: 117-119.
8. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R, (2007) Measures of adiposity and dementia risk in elderly persons. Arch Neurol 64: 392-398.
9. Stewart R, Masaki K, Xue QL, Peila R, Petrovitch H, et al. (2005) A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 62: 55-60.
10. Luchsinger JA, (2008) Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective. Eur J Pharmacol 585: 119-129.
11. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364: 937-952.
12. Dina C, Meyre D, Gallina S, Durand E, Korner A, et al. (2007) Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39: 724-726.
13. Hertel JK, Johansson S, Sonestedt E, Jonsson A, Lie RT, et al. (2011) FTO, type 2 diabetes, and weight gain throughout adult life: a meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies. Diabetes 60: 1637-1644.
14. Wang K, Li WD, Zhang CK, Wang Z, Glessner JT, et al. (2011) A genome-wide association study on obesity and obesity-related traits. PLoS One 6: e18939.
15. Zhang G, Karns R, Narancic NS, Sun G, Cheng H, et al. (2010) Common SNPs in FTO gene are associated with obesity related anthropometric traits in an island population from the eastern Adriatic coast of Croatia. PLoS One 5: e10375.
16. Hotta K, Kitamoto T, Kitamoto A, Mizusawa S, Matsuo T, et al. (2011) Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population. J Hum Genet.
17. Freathy RM, Timpson NJ, Lawlor DA, Pouta A, Ben-Shlomo Y, et al. (2008) Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes 57: 1419-1426.
18. Pausova Z, Syme C, Abrahamowicz M, Xiao Y, Leonard GT, et al. (2009) A common variant of the FTO gene is associated with not only increased adiposity but also elevated blood pressure in French Canadians. Circ Cardiovasc Genet 2: 260-269.
19. Ho AJ, Stein JL, Hua X, Lee S, Hibar DP, et al. (2010) A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A 107: 8404-8409.
20. Benedict C, Jacobsson JA, Ronnemaa E, Sallman-Almen M, Brooks S, et al. (2011) The fat mass and obesity gene is linked to reduced verbal fluency in overweight and obese elderly men. Neurobiol Aging 32: 1159 e1151-1155.
21. Keller L, Xu W, Wang HX, Winblad B, Fratiglioni L, et al. (2011) The obesity related gene, FTO, interacts with APOE, and is associated with Alzheimer's disease risk: a prospective cohort study. J Alzheimers Dis 23: 461-469.
22. Davey Smith G, Ebrahim S, (2003) 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32: 1-22.
23. Lee JH, Cheng R, Graff-Radford N, Foroud T, Mayeux R, (2008) Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci. Arch Neurol 65: 1518-1526.
24. Lee JH, Cheng R, Barral S, Reitz C, Medrano M, et al. (2011) Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol 68: 320-328.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
26. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, et al. (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56: 303-308.
27. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL, (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566-572.
28. Tang MX, Stern Y, Marder K, Bell K, Gurland B, et al. (1998) The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 279: 751-755.
29. van Boxtel MP, Henskens LH, Kroon AA, Hofman PA, Gronenschild EH, et al. (2006) Ambulatory blood pressure, asymptomatic cerebrovascular damage and cognitive function in essential hypertension. J Hum Hypertens 20: 5-13.
30. Stern Y, Andrews H, Pittman J, Sano M, Tatemichi T, et al. (1992) Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 49: 453-460.
31. Folstein MF, Folstein SE, McHugh PR, (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
32. Kaplan E, Goodglass H, Weintraub H (1983) Boston Naming Test. Philadelphia, PA Lea & Febiger.
33. Goodglass H, Kaplan E (1983) The Assessment of Aphasia and Related Disorders. 2nd ed. Philadelphia, PA Lea & Febiger.
34. Wechsler D WAIS-R Manual (1981) New York, NY The Psychological Corp.
35. Mattis S (1976) Mental status examination for organic mental syndrome in the elderly patient. In: L. Bellak& T.B. Karasu. Geriatric Psychiatry New York, NY, Grune & Statton.
36. Rosen W (1981) The Rosen Drawing Test. Bronx, NY Veterans Administration Medical Center.
37. Benton AL (1955) The Benton Visual Retention Test. New York, NY The Psychological Corp.
38. Buschke H, Fuld PA, (1974) Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 24: 1019-1025.
39. Lewandowski NM, Small SA, (2005) Brain microarray: finding needles in molecular haystacks. J Neurosci 25: 10341-10346.
40. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I, (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284.
41. Storey JD, Tibshirani R, (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100: 9440-9445.
42. Chen JJ, Roberson PK, Schell MJ, (2010) The false discovery rate: a key concept in large-scale genetic studies. Cancer Control 17: 58-62.
43. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, et al. (2005) Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement 1: 55-66.
44. Webster JA, Gibbs JR, Clarke J, Ray M, Zhang W, et al. (2009) Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet 84: 445-458.
45. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, et al. (2005) Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62: 1556-1560.
46. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41: 1088-1093.
47. Lambert JC, Heath S, Even G, Campion D, Sleegers K, et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-1099.
48. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, et al. (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303: 1832-1840.
49. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, et al. (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 43: 436-441.
50. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, et al. (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43: 429-435.
51. Haslam DW, James WP, (2005) Obesity. Lancet 366: 1197-1209.
52. Luchsinger JA, Tang MX, Shea S, Mayeux R, (2004) Hyperinsulinemia and risk of Alzheimer disease. Neurology 63: 1187-1192.
53. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, et al. (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65: 545-551.
54. Yu YH, Ginsberg HN, (2005) Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res 96: 1042-1052.